Skip to main content
Caplight Logo









BioLink

BioLink

Private
ShanghaiHealthcare & Life Scienceshttps://www.biolink.com/

Last Round

Strategic

Nov 14, 2024

Company Overview

BioLink is a life sciences company that provides process solutions, equipment, and consumables for the manufacturing of biopharmaceuticals, including vaccines, antibodies, and cell and gene therapies.

Sector

Healthcare & Life Sciences

Verticals

Biotech Equipment, Biotechnology, Medical Devices, Pharma Supply Chain

Business Model

B2B

Customer Profile

Hardware Sales, Subscription SaaS, Services & Consulting

AI Layer

Application

Keywords

bioprocessing equipmentbiomanufacturingbiotech manufacturingsingle-use technologychromatography systemsbioreactorsprocess analytical technologyPATbiopharma supply chainbioprocess developmentfiltration hardwarebiotech consumablescell and gene therapybioprocess automationlab equipment

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

BioLink Comparables

Compare BioLink with similar companies based on industry and business-model similarity.

BioLink comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Cobetter Filtration
81%
Pinshan Biotechnology (Shanghai) Co., Ltd.
80%
Suzhou Womei Biology Co., Ltd.
79%

BioLink Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
StrategicNov 14, 2024
Series A ExtensionFeb 21, 2024
Series ADec 1, 2022

BioLink Investors

Notable investors and investment history

BioLink investors
InvestorRounds
Cathay CapitalSeries A Extension, Series A, Strategic
Alwin CapitalStrategic
Boyu CapitalSeries A
Zoo CapitalStrategic
Shenzhen Capital GroupStrategic
Apricot CapitalSeries A

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jan 7, 2026

    Grew 20% QoQ, from 45 to 54 employees.

  • Dec 26, 2025

    Grew 16% QoQ, from 45 to 52 employees.

BioLink Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

BioLink Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about BioLink's valuation, stock price, and market status.

Firmographic Details

HeadquartersShanghai
Employee Range57
Year Founded2004
Last FundingNov 14, 2024

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?